Senate Health Cmte. Drug Safety Focus Will Be Antidepressants, Not Vioxx
The Senate Health Committee's oversight of FDA's drug safety regulation is likely to focus on the agency's handling of antidepressants
The Senate Health Committee's oversight of FDA's drug safety regulation is likely to focus on the agency's handling of antidepressants